Advances in diagnosis and treatment of pulmonary hypertension based on the 2022 ESC Guidelines.
10.3760/cma.j.cn112148-20221020-00820
- Author:
Run Wei DENG
1
;
You Li FAN
1
;
Bing Xiang WU
1
Author Information
1. Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin 150086, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Hypertension, Pulmonary/drug therapy*;
Antihypertensive Agents/therapeutic use*;
Cardiology;
Hypertension/drug therapy*
- From:
Chinese Journal of Cardiology
2023;51(3):314-319
- CountryChina
- Language:Chinese
